Amphastar Pharmaceuticals market cap is $870.3 m, and annual revenue was $322.36 m in FY 2019

Amphastar Pharmaceuticals Gross profit (Q3, 2020)36.5 M

Amphastar Pharmaceuticals Gross profit margin (Q3, 2020), %43.8%

Amphastar Pharmaceuticals Net income (Q3, 2020)4.8 M

Amphastar Pharmaceuticals EBIT (Q3, 2020)3.5 M

Amphastar Pharmaceuticals Cash, 30-Sept-202087.9 M

Amphastar Pharmaceuticals EV848.6 M

Amphastar Pharmaceuticals revenue was $322.36 m in FY, 2019

Amphastar Pharmaceuticals revenue breakdown by business segment: 94.1% from Finished pharmaceutical products and 5.9% from Active Pharmaceutical Ingredients

USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|

## Revenue | 210.5m | 251.5m | 255.2m | 240.2m | 294.7m | 322.4m |

| 20% | 1% | ||||

## Cost of goods sold | 159.2m | 174.2m | 151.0m | 149.4m | 187.7m | 190.4m |

## Gross profit | 51.3m | 77.3m | 104.2m | 90.8m | 107.0m | 131.9m |

| 24% | 31% | 41% | 38% | 36% | 41% |

## Sales and marketing expense | 5.6m | 5.5m | 5.5m | 6.5m | 8.2m | 12.8m |

## R&D expense | 28.4m | 37.1m | 41.2m | 43.4m | 57.6m | 68.9m |

## General and administrative expense | 34.8m | 41.5m | 41.8m | 44.5m | 49.9m | 50.3m |

## Operating expense total | 69.2m | 84.2m | 88.5m | 91.7m | 115.6m | 132.0m |

## EBIT | (18.0m) | (6.9m) | 15.7m | (895.0k) | (8.6m) | (39.0k) |

| (9%) | (3%) | 6% | 0% | (3%) | 0% |

## Interest expense | 165.0k | 3.5m | 746.0k | 2.5m | 1.3m | |

## Interest income | 243.0k | 315.0k | 270.0k | 425.0k | 456.0k | 997.0k |

## Pre tax profit | (18.1m) | (10.4m) | 14.9m | 1.6m | (9.9m) | 60.2m |

## Income tax expense | (7.4m) | (7.6m) | 4.4m | (2.9m) | (3.3m) | 13.7m |

## Net Income | (10.7m) | (2.8m) | 10.5m | 4.5m | (5.7m) | 46.5m |

- Source: SEC Filings

- Source: SEC Filings

USD | Y, 2012 | Y, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|

## Cash | 50.2m | 53.6m | 67.8m | 66.1m | 72.4m | 65.6m | 86.3m | 73.7m |

## Accounts Receivable | 22.9m | 33.2m | 26.8m | 36.0m | 52.2m | 45.4m | ||

## Prepaid Expenses | 9.8m | 5.5m | 9.5m | |||||

## Inventories | 118.4m | 63.6m | 69.3m | 110.5m | ||||

## Current Assets | 198.0m | 175.9m | 184.1m | 187.8m | 220.3m | 255.2m | ||

## PP&E | 138.3m | 142.2m | 152.9m | 185.3m | 210.4m | 233.9m | ||

## Goodwill | 42.6m | 39.9m | 50.3m | 45.1m | 42.3m | 41.2m | ||

## Total Assets | 389.4m | 390.1m | 427.7m | 454.7m | 513.6m | 587.0m | ||

## Accounts Payable | 10.2m | 13.9m | 16.2m | 16.6m | 31.3m | 25.1m | ||

## Short-term debt | 6.3m | 18.2m | 10.9m | |||||

## Current Liabilities | 62.6m | 60.0m | 60.6m | 67.2m | 106.8m | 90.0m | ||

## Long-term debt | 40.8m | 32.0m | 55.7m | |||||

## Total Debt | 47.2m | 50.2m | 66.6m | |||||

## Total Liabilities | 98.5m | 117.3m | 149.2m | 159.4m | ||||

## Common Stock | 5.0k | 5.0k | 5.0k | |||||

## Additional Paid-in Capital | 220.7m | 247.8m | 283.1m | 313.9m | 344.4m | 367.3m | ||

## Retained Earnings | 63.1m | 60.3m | 70.9m | 76.2m | 67.5m | 116.4m | ||

## Total Equity | 295.5m | 329.3m | 337.3m | 364.4m | 427.5m | |||

## Financial Leverage | 1.3 x | 1.3 x | 1.3 x | 1.4 x | 1.4 x |

- Source: SEC Filings

- Source: SEC Filings

USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|

## Net Income | (10.7m) | (2.8m) | 10.5m | 4.5m | (6.7m) | 46.5m |

## Depreciation and Amortization | 12.0m | 15.4m | 16.5m | 18.1m | ||

## Accounts Receivable | 1.2m | 6.4m | (8.1m) | (16.3m) | 6.7m | |

## Inventories | 9.1m | (9.7m) | 18.7m | (6.0m) | (41.1m) | |

## Accounts Payable | 7.0m | 6.7m | 29.2m | (11.7m) | ||

## Cash From Operating Activities | 14.2m | (1.8m) | 38.6m | 39.2m | 38.2m | 41.8m |

## Purchases of PP&E | (18.7m) | (35.1m) | (46.8m) | (41.6m) | ||

## Cash From Investing Activities | (39.8m) | (39.5m) | (38.8m) | (42.2m) | (50.5m) | |

## Short-term Borrowings | (347.0k) | |||||

## Long-term Borrowings | (8.2m) | (14.7m) | (9.7m) | (5.7m) | (6.4m) | |

## Cash From Financing Activities | 32.1m | 7.1m | (7.7m) | 25.0m | (3.8m) | |

## Net Change in Cash | (6.8m) | 20.7m | (12.7m) | |||

## Interest Paid | 2.6m | 1.9m | 2.4m | 2.4m | ||

## Income Taxes Paid | 436.0k | 3.4m | 4.9m | 339.0k | 5.7m |

- Source: SEC Filings

- Source: SEC Filings

USD | Y, 2012 |
---|